Title:
NOVEL COMPOUND HAVING INHIBITORY ACTIVITY AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/163527
Kind Code:
A1
Abstract:
The present invention relates to a novel compound having inhibitory activity against epidermal growth factor receptor tyrosine kinase and to uses thereof, and provided in the present invention are a compound represented by chemical formula I, a solvate, a stereoisomer or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same.
Inventors:
CHOI SUNG PIL (KR)
LIM SANG KYUN (KR)
MIN KYUNG HOON (KR)
KIM MIYEON (KR)
JANG AN NA (KR)
LEE YERI (KR)
KIM DONG SU (KR)
SONG JI HO (KR)
LIM SANG KYUN (KR)
MIN KYUNG HOON (KR)
KIM MIYEON (KR)
JANG AN NA (KR)
LEE YERI (KR)
KIM DONG SU (KR)
SONG JI HO (KR)
Application Number:
PCT/KR2023/002611
Publication Date:
August 31, 2023
Filing Date:
February 23, 2023
Export Citation:
Assignee:
KANAPH THERAPEUTICS INC (KR)
UNIV CHUNG ANG IND ACAD COOP FOUND (KR)
UNIV CHUNG ANG IND ACAD COOP FOUND (KR)
International Classes:
C07D498/10; A61K31/519; A61K31/5377; A61P35/00; C07D498/08
Domestic Patent References:
| WO2021216440A1 | 2021-10-28 | |||
| WO2016014551A1 | 2016-01-28 |
Foreign References:
| KR20190114910A | 2019-10-10 | |||
| KR20210046914A | 2021-04-29 | |||
| KR20050058360A | 2005-06-16 |
Attorney, Agent or Firm:
RYU, Jong Woo et al. (KR)
Download PDF: